Literature DB >> 20843753

Ileal biopsy: Clinical indications, endoscopic and histopathologic findings in 10,000 patients.

Shelby D Melton1, Linda A Feagins, M Hossein Saboorian, Robert M Genta.   

Abstract

BACKGROUND: Ileal biopsies are often reported as having a low yield. Data from endoscopy practices in the private setting are lacking. AIMS: To correlate the frequency of histologic abnormalities in ileal biopsies with clinical indications and ileoscopic appearances.
METHODS: Retrospective analysis of clinical, endoscopic, and histopathologic data from a large database.
RESULTS: We studied 9785 unique adult patients (median age 46 years, 61.4% women) with ileal biopsies. The most common symptoms were diarrhoea (52.2%) and abdominal pain (37.1%). Ileoscopy was reported as being normal in 75.1% patients. Subjects screened for cancer had the highest prevalence of abnormal endoscopic findings (63.3%); patients with known or suspected Crohn's had the highest prevalence abnormal ileal histology (36.4%). Overall, 5.0% of ileal biopsies obtained from patients with normal endoscopy and 47.4% of biopsies from patients with an endoscopically abnormal ileum had significant histopathologic findings.
CONCLUSIONS: In adults, biopsies from the endoscopically normal ileum rarely provide clinically relevant information and cannot be recommended. In contrast, half of the adult patients with an endoscopically abnormal ileum have significant histopathologic findings in ileal biopsies. Therefore, ileoscopy associated with a sensible use of the ileal biopsy is a valuable complement to the colonoscopy. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20843753     DOI: 10.1016/j.dld.2010.08.004

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  8 in total

1.  Proliferation and apoptosis of Peyer's patches and its lymphocytes in experimental terminal ileitis.

Authors:  Wei Wang; Ailei Xu; Guohua Zhou; Mingfang Leng; Hongyu Zhou; Jun Yan
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

2.  Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis.

Authors:  Manasi Agrawal; Mario Bento- Miranda; Samantha Walsh; Neeraj Narula; Jean-Frederic Colombel; Ryan C Ungaro
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

3.  Patient-posture and Ileal-intubation during colonoscopy (PIC): a randomized controlled open-label trial.

Authors:  Sk Mahiuddin Ahammed; Kshaunish Das; R Sarkar; J Dasgupta; S Bandopadhyay; G K Dhali
Journal:  Endosc Int Open       Date:  2014-05-07

4.  How does a biopsy of endoscopically normal terminal ileum contribute to the diagnosis? Which patients should undergo biopsy?

Authors:  Ali Riza Koksal; Salih Boga; Huseyin Alkim; Meltem Ergun; Mehmet Bayram; Damlanur Sakiz; Osman Ozdogan; Engin Altinkaya; Canan Alkim
Journal:  Libyan J Med       Date:  2014-02-19       Impact factor: 1.743

5.  The Utility of Endoscopic Biopsies in Patients with Normal Upper Endoscopy.

Authors:  Anouar Teriaky; Abdullah AlNasser; Carolyn McLean; James Gregor; Brian Yan
Journal:  Can J Gastroenterol Hepatol       Date:  2016-07-10

6.  Analysis and Follow up of Endoscopy Results in 1099 Patients with Terminal Ileum Lesions.

Authors:  Qinglian Zhong; Anye Zhang; Jian Huang; Wen Yan; Jiayu Lin; Qun Huang; Xiaoshan Huang; Tao Yu; Luhong Zhu; Chen Xu
Journal:  Can J Gastroenterol Hepatol       Date:  2020-12-04

7.  Development of a Score to Predict Positive Colonic Histology in Chronic Diarrhea Assessed in Open-access Colonoscopy.

Authors:  Jessica Atieh; Victor Chedid; Katayoun Khoshbin; Sunanda Kane; Michael Camilleri
Journal:  J Clin Gastroenterol       Date:  2021-09-01       Impact factor: 3.174

8.  Can microscopic ileitis in patients with clinically suspected inflammatory bowel disease predict the future?

Authors:  Fadi Abu Baker; Jesus Alonso Z'cruz De La Garza; Smadar Nafrin; Amir Mari; Muhammed Suki; Baruch Ovadia; Oren Gal; Yael Kopelamn
Journal:  BMC Gastroenterol       Date:  2020-03-05       Impact factor: 2.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.